Skip to content

Repeatability of X-Ray, MRI, and Gait Analysis

Repeatability of X-Ray, MRI, and Gait Analysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00581841
Enrollment
60
Registered
2007-12-28
Start date
2002-11-30
Completion date
2003-06-30
Last updated
2013-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Healthy adult normals

Brief summary

The purpose of this preliminary substudy to the parent study Aerobic Exercise Intervention for Knee Osteoarthritis is to determine the repeatability and reproducibility of various measurement techniques.

Detailed description

The purpose of this preliminary substudy to the parent study Aerobic Exercise Intervention for Knee Osteoarthritis is to determine the repeatability and reproducibility of various measurement techniques. The study will enroll healthy volunteers. All participants will receive x-rays and MRI examinations of the knees. Walking characteristics will be evaluated in a Motion Analysis Lab; this will involve taping reflective markers to participants' skin and having them walk on a level surface and up and down stairs. All participants will be evaluated two times, with a 1-week period between evaluations.

Interventions

OTHERGait analysis, knee x-ray, and knee MRI

Gait analysis, knee x-rays, and knee MRIs will be done twice for each participant, 1 week apart.

Sponsors

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
CollaboratorNIH
Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults

Exclusion criteria

* Previous knee injury, knee pain, or knee osteoarthritis

Design outcomes

Primary

MeasureTime frame
Day-to-day and inter/intra examiner repeatability of the techniques to be used in NIH grant R01 AR48768Measured two times, with a 1-week period between evaluations

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026